These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3332681)
21. Effects of subtenon-injected autologous platelet-rich plasma on visual functions in eyes with retinitis pigmentosa: preliminary clinical results. Arslan U; Özmert E; Demirel S; Örnek F; Şermet F Graefes Arch Clin Exp Ophthalmol; 2018 May; 256(5):893-908. PubMed ID: 29546474 [TBL] [Abstract][Full Text] [Related]
22. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ Arch Ophthalmol; 2004 Sep; 122(9):1306-14. PubMed ID: 15364709 [TBL] [Abstract][Full Text] [Related]
23. Disease course of patients with pericentral retinitis pigmentosa. Sandberg MA; Gaudio AR; Berson EL Am J Ophthalmol; 2005 Jul; 140(1):100-6. PubMed ID: 15953579 [TBL] [Abstract][Full Text] [Related]
24. Natural course of retinitis pigmentosa over a three-year interval. Berson EL; Sandberg MA; Rosner B; Birch DG; Hanson AH Am J Ophthalmol; 1985 Mar; 99(3):240-51. PubMed ID: 3976802 [TBL] [Abstract][Full Text] [Related]
25. [Long-term follow-up of a case of unilateral retinitis pigmentosa]. Kato K; Miyake Y; Matsubara H; Uji Y Nippon Ganka Gakkai Zasshi; 2012 Nov; 116(11):1086-93. PubMed ID: 23316657 [TBL] [Abstract][Full Text] [Related]
26. The clinical significance of retinitis pigmentosa without pigment: a computer assisted analysis. Pearlman JT; Saxton J; Flood TP; Seiff SR Adv Exp Med Biol; 1977; 77():31-5. PubMed ID: 322461 [TBL] [Abstract][Full Text] [Related]
27. Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin:Retinol Acyltransferase (LRAT). Scholl HP; Moore AT; Koenekoop RK; Wen Y; Fishman GA; van den Born LI; Bittner A; Bowles K; Fletcher EC; Collison FT; Dagnelie G; Degli Eposti S; Michaelides M; Saperstein DA; Schuchard RA; Barnes C; Zein W; Zobor D; Birch DG; Mendola JD; Zrenner E; PLoS One; 2015; 10(12):e0143846. PubMed ID: 26656277 [TBL] [Abstract][Full Text] [Related]
28. Comparison of intraocular light scatter in carriers of choroideremia and X-linked retinitis pigmentosa. Grover S; Alexander KR; Fishman GA; Ryan J Ophthalmology; 2002 Jan; 109(1):159-63. PubMed ID: 11772598 [TBL] [Abstract][Full Text] [Related]
29. Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Berson EL; Rosner B; Sandberg MA; Weigel-DiFranco C; Moser A; Brockhurst RJ; Hayes KC; Johnson CA; Anderson EJ; Gaudio AR; Willett WC; Schaefer EJ Arch Ophthalmol; 2004 Sep; 122(9):1297-305. PubMed ID: 15364708 [TBL] [Abstract][Full Text] [Related]
30. Transcorneal Electrical Stimulation for Patients With Retinitis Pigmentosa: A Prospective, Randomized, Sham-Controlled Follow-up Study Over 1 Year. Schatz A; Pach J; Gosheva M; Naycheva L; Willmann G; Wilhelm B; Peters T; Bartz-Schmidt KU; Zrenner E; Messias A; Gekeler F Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):257-269. PubMed ID: 28114587 [TBL] [Abstract][Full Text] [Related]
32. Vitamin A supplementation for retinitis pigmentosa. Berson EL; Rosner B; Sandberg MA; Hayes KC; Nicholson BW; Weigel-DiFrano C; Willett W Arch Ophthalmol; 1993 Nov; 111(11):1456-9. PubMed ID: 8240091 [No Abstract] [Full Text] [Related]
33. Rod visual fields in cone-rod degeneration. Comparisons to retinitis pigmentosa. Birch DG; Anderson JL Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2288-99. PubMed ID: 2242994 [TBL] [Abstract][Full Text] [Related]
34. Full-field ERG, multifocal ERG and multifocal VEP in patients with retinitis pigmentosa and residual central visual fields. Gränse L; Ponjavic V; Andréasson S Acta Ophthalmol Scand; 2004 Dec; 82(6):701-6. PubMed ID: 15606467 [TBL] [Abstract][Full Text] [Related]
35. Long-term Follow-up of Patients With Retinitis Pigmentosa Receiving Intraocular Ciliary Neurotrophic Factor Implants. Birch DG; Bennett LD; Duncan JL; Weleber RG; Pennesi ME Am J Ophthalmol; 2016 Oct; 170():10-14. PubMed ID: 27457255 [TBL] [Abstract][Full Text] [Related]
36. Long-term effect of acetazolamide in a patient with retinitis pigmentosa. Chen JC; Fitzke FW; Bird AC Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1914-8. PubMed ID: 2211037 [TBL] [Abstract][Full Text] [Related]
37. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Siqueira RC; Messias A; Voltarelli JC; Scott IU; Jorge R Retina; 2011 Jun; 31(6):1207-14. PubMed ID: 21293313 [TBL] [Abstract][Full Text] [Related]
38. Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa. Berson EL; Weigel-DiFranco C; Rosner B; Gaudio AR; Sandberg MA JAMA Ophthalmol; 2018 May; 136(5):490-495. PubMed ID: 29596553 [TBL] [Abstract][Full Text] [Related]
39. Reduced Central Retinal Artery Blood Flow Is Related to Impaired Central Visual Function in Retinitis Pigmentosa Patients. Kayser S; Vargas P; Mendelsohn D; Han J; Bi H; Benavente A; Bittner AK Curr Eye Res; 2017 Nov; 42(11):1503-1510. PubMed ID: 28910168 [TBL] [Abstract][Full Text] [Related]
40. Cone electroretinographic change during light adaptation in retinitis pigmentosa. Miller S; Sandberg MA Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2536-41. PubMed ID: 1869408 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]